Dazostinag enhances tumor cell apoptosis in head and neck squamous cell carcinoma, suggesting potential therapeutic implications for chemotherapy combinations.
Dazostinag + CPPT + PTX induced tumor cell apoptosis at 24 hours postintratumoral injection. Staining with the apoptosis marker CC3 showed minimal change at sites with dazostinag alone, a modest increase when treated with carboplatin + paclitaxel, and significantly elevated CC3 at sites with dazostinag + carboplatin + paclitaxel. Cell nuclei, blue; CC3, red; CIVO GLO, green. The number of regions of interest analyzed for each patient and drug conditions is detailed in Supplementary Table S4. CC3, cleaved caspase-3; CPPT, carboplatin; PTX, paclitaxel.
No takes yet. Share an insight, caveat, or question.
Gregory et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: